Literature DB >> 16145150

Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia.

Thierry Naas1, Marc Levy, Claire Hirschauer, Hélène Marchandin, Patrice Nordmann.   

Abstract

Carbapenem-resistant Acinetobacter baumannii isolates were obtained from 24 patients between March and May 2004 at the Centre Hospitalier de Polynésie Française, Tahiti, French Polynesia. The isolates were multidrug resistant, produced the carbapenemase OXA-23, and belonged to a single clone presenting several subtypes, suggesting an endemic situation. This study further illustrates the global spread of this kind of beta-lactamase-mediated resistance.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16145150      PMCID： PMC1234128          DOI： 10.1128/JCM.43.9.4826-4829.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

1.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.

Authors:  Laurent Poirel; Sophie Marqué; Claire Héritier; Christine Segonds; Gérard Chabanon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

3.  Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.

Authors:  M Afzal-Shah; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.

Authors:  G Bou; G Cerveró; M A Domínguez; C Quereda; J Martínez-Beltrán
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  OXA-24, a novel class D beta-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain.

Authors:  G Bou; A Oliver; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

7.  CDC definitions for nosocomial infections, 1988.

Authors:  J S Garner; W R Jarvis; T G Emori; T C Horan; J M Hughes
Journal:  Am J Infect Control       Date:  1988-06       Impact factor: 2.918

Review 8.  Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support.

Authors:  L Poirel; P Nordmann
Journal:  Curr Pharm Biotechnol       Date:  2002-06       Impact factor: 2.837

9.  ARI 1: beta-lactamase-mediated imipenem resistance in Acinetobacter baumannii.

Authors:  R Paton; R S Miles; J Hood; S G Amyes; R S Miles; S G Amyes
Journal:  Int J Antimicrob Agents       Date:  1993-02       Impact factor: 5.283

10.  Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate.

Authors:  Heidi Segal; E C Nelson; B Gay Elisha
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191
View more
  32 in total

1.  Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.

Authors:  Karen Lolans; Thomas W Rice; L Silvia Munoz-Price; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.

Authors:  Maria Virginia Villegas; Juan Nicolas Kattan; Adriana Correa; Karen Lolans; Ana Maria Guzman; Neil Woodford; David Livermore; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

3.  Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii.

Authors:  Stéphane Corvec; Laurent Poirel; Thierry Naas; Henri Drugeon; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

Review 4.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

Review 5.  Global challenge of multidrug-resistant Acinetobacter baumannii.

Authors:  Federico Perez; Andrea M Hujer; Kristine M Hujer; Brooke K Decker; Philip N Rather; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2007-07-23       Impact factor: 5.191

6.  Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.

Authors:  Pierre Bogaerts; Gaelle Cuzon; Thierry Naas; Caroline Bauraing; Ariane Deplano; Bénédicte Lissoir; Patrice Nordmann; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2008-09-02       Impact factor: 5.191

7.  Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar.

Authors:  Tahiry S Andriamanantena; Elisoa Ratsima; Hanitra C Rakotonirina; Frédérique Randrianirina; Lovasoa Ramparany; Jean-François Carod; Vincent Richard; Antoine Talarmin
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-06-30       Impact factor: 3.944

Review 8.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

9.  Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.

Authors:  Hee Young Yang; Hee Joo Lee; Jin Tae Suh; Kyeong Min Lee
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

10.  Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii.

Authors:  Pauline D Mugnier; Laurent Poirel; Thierry Naas; Patrice Nordmann
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.